Us Congress 2025-2026 Regular Session

Us Congress House Bill HB767 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 I
22 119THCONGRESS
33 1
44 STSESSION H. R. 767
55 To amend the Public Health Service Act to authorize the Biomedical Ad-
66 vanced Research and Development Authority to award follow-on produc-
77 tion contracts or transactions, procure supplies for experimental or test
88 purposes, and acquire innovative commercial products and commercial
99 services, and for other purposes.
1010 IN THE HOUSE OF REPRESENTATIVES
1111 JANUARY28, 2025
1212 Mr. G
1313 ARCIAof California introduced the following bill; which was referred to
1414 the Committee on Energy and Commerce
1515 A BILL
1616 To amend the Public Health Service Act to authorize the
1717 Biomedical Advanced Research and Development Author-
1818 ity to award follow-on production contracts or trans-
1919 actions, procure supplies for experimental or test pur-
2020 poses, and acquire innovative commercial products and
2121 commercial services, and for other purposes.
2222 Be it enacted by the Senate and House of Representa-1
2323 tives of the United States of America in Congress assembled, 2
2424 SECTION 1. SHORT TITLE. 3
2525 This Act may be cited as the ‘‘Fast-Track Logistics 4
2626 for Acquiring Supplies in a Hurry Act of 2025’’ or the 5
2727 ‘‘FLASH Act of 2025’’. 6
2828 VerDate Sep 11 2014 20:38 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H767.IH H767
2929 ssavage on LAPJG3WLY3PROD with BILLS 2
3030 •HR 767 IH
3131 SEC. 2. AUTHORITY TO AWARD FOLLOW-ON PRODUCTION 1
3232 CONTRACTS OR TRANSACTIONS, PROCURE 2
3333 SUPPLIES FOR EXPERIMENTAL OR TEST PUR-3
3434 POSES, AND ACQUIRE INNOVATIVE COMMER-4
3535 CIAL PRODUCTS AND COMMERCIAL SERV-5
3636 ICES. 6
3737 Section 319L of the Public Health Service Act (42 7
3838 U.S.C. 247d–7e) is amended— 8
3939 (1) in subsection (a)(6)(B), by amending clause 9
4040 (ii) to read as follows: 10
4141 ‘‘(ii) design and development of— 11
4242 ‘‘(I) tests and prototypes, includ-12
4343 ing obtaining sufficient quantities for 13
4444 evaluation of such tests and proto-14
4545 types; and 15
4646 ‘‘(II) models, including animal 16
4747 models, for such testing and proto-17
4848 types;’’; and 18
4949 (2) in subsection (c)(5)— 19
5050 (A) in subparagraph (A)— 20
5151 (i) by redesignating clause (iv) as 21
5252 clause (v); and 22
5353 (ii) by inserting after clause (iii) the 23
5454 following new clause: 24
5555 ‘‘(iv) F
5656 OLLOW-ON PRODUCTION CON -25
5757 TRACTS OR TRANSACTIONS .— 26
5858 VerDate Sep 11 2014 20:38 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H767.IH H767
5959 ssavage on LAPJG3WLY3PROD with BILLS 3
6060 •HR 767 IH
6161 ‘‘(I) IN GENERAL.—A transaction 1
6262 entered into under this subparagraph 2
6363 for the design or development of a 3
6464 prototype may provide for the award 4
6565 of a follow-on production contract or 5
6666 transaction to the participants in the 6
6767 transaction. 7
6868 ‘‘(II) P
6969 ROTOTYPE SUB -8
7070 PROJECTS.—A transaction entered 9
7171 into under this subparagraph includes 10
7272 all prototype subprojects awarded 11
7373 under the transaction to carry out au-12
7474 thorities under this section. 13
7575 ‘‘(III) E
7676 XCEPTION TO COMPETI -14
7777 TIVE PROCEDURES.—Notwithstanding 15
7878 clause (ii), a follow-on production con-16
7979 tract or transaction provided for in a 17
8080 transaction under this clause may be 18
8181 awarded to the participants in the 19
8282 transaction without the use of com-20
8383 petitive procedures, even if explicit no-21
8484 tification was not listed within the re-22
8585 quest for proposal for the transaction, 23
8686 if competitive procedures were used 24
8787 VerDate Sep 11 2014 20:38 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H767.IH H767
8888 ssavage on LAPJG3WLY3PROD with BILLS 4
8989 •HR 767 IH
9090 for the selection of parties for partici-1
9191 pation in the initial transaction.’’; and 2
9292 (B) by adding at the end the following new 3
9393 subparagraphs: 4
9494 ‘‘(I) P
9595 ROCUREMENT FOR EXPERIMENTAL 5
9696 OR TEST PURPOSES.— 6
9797 ‘‘(i) I
9898 N GENERAL.—The Secretary 7
9999 may purchase medical countermeasures, 8
100100 products, and supplies, chemical materials 9
101101 and reagents, manufacturing supplies, pro-10
102102 tective equipment, and such other supplies, 11
103103 including parts and accessories, and de-12
104104 signs thereof, as the Secretary determines 13
105105 necessary for experimental or test purposes 14
106106 in the development of supplies that are 15
107107 necessary for national public health and 16
108108 health security. 17
109109 ‘‘(ii) P
110110 ROCEDURES.—Notwithstanding 18
111111 subparagraph (A)(ii), the Secretary may 19
112112 make purchases under this subparagraph 20
113113 by contract, or by entering into a trans-21
114114 action other than a contract, using non-22
115115 competitive procedures. 23
116116 ‘‘(J) A
117117 CQUISITION OF INNOVATIVE COM -24
118118 MERCIAL PRODUCTS AND COMMERCIAL SERV -25
119119 VerDate Sep 11 2014 20:38 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H767.IH H767
120120 ssavage on LAPJG3WLY3PROD with BILLS 5
121121 •HR 767 IH
122122 ICES USING GENERAL SOLICITATION COMPETI -1
123123 TIVE PROCEDURES.— 2
124124 ‘‘(i) I
125125 N GENERAL.—Notwithstanding 3
126126 subparagraph (A)(ii), the Secretary may 4
127127 acquire innovative commercial products 5
128128 and commercial services through a com-6
129129 petitive selection of proposals resulting 7
130130 from a general solicitation and the peer re-8
131131 view of such proposals. 9
132132 ‘‘(ii) T
133133 REATMENT AS COMPETITIVE 10
134134 PROCEDURES.—Use of general solicitation 11
135135 competitive procedures under clause (i) 12
136136 shall be considered to be use of competitive 13
137137 procedures for purposes of chapter 33 of 14
138138 title 41, United States Code. 15
139139 ‘‘(iii) L
140140 IMITATIONS.— 16
141141 ‘‘(I) T
142142 RANSACTIONS IN EXCESS 17
143143 OF $100,000,000.—The Secretary may 18
144144 not enter into a contract or agreement 19
145145 in excess of $100,000,000 using the 20
146146 authority under clause (i), unless the 21
147147 Secretary makes a written determina-22
148148 tion of the efficacy of the effort to 23
149149 meet mission needs of the Department 24
150150 of Health and Human Services. 25
151151 VerDate Sep 11 2014 20:38 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H767.IH H767
152152 ssavage on LAPJG3WLY3PROD with BILLS 6
153153 •HR 767 IH
154154 ‘‘(II) FIXED-PRICE.—Contracts 1
155155 or agreements entered into using the 2
156156 authority under clause (i) shall be 3
157157 fixed-price, including fixed-price in-4
158158 centive contracts. 5
159159 ‘‘(iv) C
160160 ONGRESSIONAL NOTIFICATION 6
161161 REQUIRED.— 7
162162 ‘‘(I) S
163163 UBMISSION.—Not later 8
164164 than 45 days after the award of a 9
165165 contract for an amount exceeding 10
166166 $100,000,000 using the authority 11
167167 under clause (i), the Secretary shall 12
168168 provide notification of such award to 13
169169 the Committee on Energy and Com-14
170170 merce and the Committee on Appro-15
171171 priations of the House of Representa-16
172172 tives, and the Committee on Health, 17
173173 Education, Labor, and Pensions and 18
174174 the Committee on Appropriations of 19
175175 the Senate. 20
176176 ‘‘(II) C
177177 ONTENTS.—Notification 21
178178 of an award under subclause (I) shall 22
179179 include the following: 23
180180 VerDate Sep 11 2014 20:38 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H767.IH H767
181181 ssavage on LAPJG3WLY3PROD with BILLS 7
182182 •HR 767 IH
183183 ‘‘(aa) Description of the in-1
184184 novative commercial product or 2
185185 commercial service acquired. 3
186186 ‘‘(bb) Description of the re-4
187187 quirement, capability gap, or po-5
188188 tential technological advancement 6
189189 with respect to which the innova-7
190190 tive commercial product or com-8
191191 mercial service acquired provides 9
192192 a solution or a potential new ca-10
193193 pability. 11
194194 ‘‘(cc) Amount of the con-12
195195 tract awarded. 13
196196 ‘‘(dd) Identification of the 14
197197 contractor awarded the contract. 15
198198 ‘‘(v) I
199199 NNOVATIVE DEFINED .—In this 16
200200 subparagraph, the term ‘innovative’, with 17
201201 respect to a commercial product or com-18
202202 mercial service, means— 19
203203 ‘‘(I) any technology, process, or 20
204204 method, including research and devel-21
205205 opment, that is new as of the date of 22
206206 submission of a proposal; or 23
207207 ‘‘(II) with respect to a tech-24
208208 nology, process, or method, including 25
209209 VerDate Sep 11 2014 20:38 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\H767.IH H767
210210 ssavage on LAPJG3WLY3PROD with BILLS 8
211211 •HR 767 IH
212212 research and development, existing as 1
213213 of the date of submission of a pro-2
214214 posal, any application of such tech-3
215215 nology, process, or method that is new 4
216216 to the Federal Government as of such 5
217217 date.’’. 6
218218 Æ
219219 VerDate Sep 11 2014 20:38 Feb 24, 2025 Jkt 059200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6301 E:\BILLS\H767.IH H767
220220 ssavage on LAPJG3WLY3PROD with BILLS